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Abstract
Mutations in insulin/IGF-1 signaling pathway have been shown to lead to increased longevity in various invertebrate
models. Therefore, the effect of the haplo- insufficiency of the IGF-1 receptor (Igf1r
+/2) on longevity/aging was evaluated in
C57Bl/6 mice using rigorous criteria where lifespan and end-of-life pathology were measured under optimal husbandry
conditions using large sample sizes. Igf1r
+/2 mice exhibited reductions in IGF-1 receptor levels and the activation of Akt by
IGF-1, with no compensatory increases in serum IGF-1 or tissue IGF-1 mRNA levels, indicating that the Igf1r
+/2 mice show
reduced IGF-1 signaling. Aged male, but not female Igf1r
+/2 mice were glucose intolerant, and both genders developed
insulin resistance as they aged. Female, but not male Igf1r
+/2 mice survived longer than wild type mice after lethal paraquat
and diquat exposure, and female Igf1r
+/2 mice also exhibited less diquat-induced liver damage. However, no significant
difference between the lifespans of the male Igf1r
+/2 and wild type mice was observed; and the mean lifespan of the
Igf1r
+/2 females was increased only slightly (less than 5%) compared to wild type mice. A comprehensive pathological
analysis showed no significant difference in end-of-life pathological lesions between the Igf1r
+/2 and wild type mice. These
data show that the Igf1r
+/2 mouse is not a model of increased longevity and delayed aging as predicted by invertebrate
models with mutations in the insulin/IGF-1 signaling pathway.
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Introduction
One of the major discoveries in aging during the past decade
has been the observation that mutations in insulin/IGF-1 signaling
led to increased longevity in various invertebrate models [1].
Hypomorphic alleles of the age-1 [2] and daf-2 [3] genes, orthologs
of phosphoinositol-3-kinase [4], and the insulin/IGF-1 receptor
[5] extend lifespan in C. elegans [6,7]. Mutations in the insulin/IGF
receptor (InR) also increase the median lifespan of female
Drosophila [8] as do mutations in CHICO, the Drosophila IRS1
(insulin receptor substrate 1) ortholog [9]. Selman et al. [10]
reported that female mice null for insulin receptor substrate 1
(Irs1) showed a 32% increase in median lifespan compared to WT
while male Irs1
2/2 mice showed no significant increase in lifespan.
In contrast, mice null for Irs2 die before 30 months of age.
Taguchi et al. [11] reported that Irs2
+/2 mice lived 17% longer
than WT mice. However, neither the number of mice nor the sex
of the mice was given, and in a subsequent lifespan study, Selman
et al. [12] found no significant increase in the lifespan of either
male or female Irs2
+/2 mice compared to their WT littermates.
Irs1 is thought to be more important in mitogenic signaling
whereas Irs2 is more involved in metabolic signaling [13] so the
more robust lifespan extending effect in Irs1 mutants could be due
to reduced cell division while Irs2 mutants may fail to show robust
lifespan extension due to metabolic dysregulation These data point
to the complexities that alterations in components of the IGF-1/
insulin signaling pathway might have on mammalian aging.
The most direct evidence that mutations affecting the insulin/
IGF-1 signaling pathway lead to increased longevity in mammals
has come from studies with Igf1r
+/2 mice (i.e., mice lacking one
copy of the gene coding for IGF-1 receptor; mice lacking both
copies die shortly after birth but the Igf1r
+/2 mice were reported to
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reported that female Igf1r
+/2 mice exhibited a 33% increase in
lifespan and were resistant to the oxidative stressor, paraquat.
Males showed a statistically non-significant 16% increase in life-
span, and were not resistant to paraquat. These data supported the
previous studies in invertebrates showing that reduced IGF-1
receptor (IGF-1R) signaling also leads to increased lifespan in
mammals.
However, the lifespan data in the Holzenberger study are
problematic because of the small sample size and the very short
lifespan of both the wild type (WT) and Igf1r
+/2 mice studied
(reviewed in [16] and [17]); therefore, we have reassessed the effect
of reduced expression of the IGF-1R on lifespan using the rigorous
criteria recommended by Ladiges et al. [18], e.g., lifespan and
end-of-life pathology were assessed using large sample sizes and
husbandry conditions that permitted the control lifespan to
approach its full potential, which are necessary if the longevity
differences in the experimental group are to be relevant to healthy
aging. In agreement with Holzenberger et al. [15], we found that
the female Igf1r
+/2 mice were more resistant to the oxidative stress
than were WT female mice while no difference was observed
between the male Igf1r
+/2 and WT mice. However, there was only
a modest increase in the mean lifespan (4.7%) of female Igf1r
+/2
mice compared to their WT littermates and no significant change
in end-of-life pathology. Thus, our data show that haploinsuffi-
ciency of Igf1r does not produce a robust increase in lifespan as
previously reported, demonstrating that reduced IGF-1R signaling
in mammals does not play the same major role in aging that is
observed in invertebrates.
Materials and Methods
Ethics Statement
All procedures involving mice were approved by the subcom-
mittee for Animal Studies at the Audie L. Murphy Veterans
Administration Hospital (protocol #0508-001, ‘‘Role of IGF-1
Receptor in Aging and Age-Related Diseases’’) and the University
of Texas Health Science Center at San Antonio IACUC (protocol
#06053, ‘‘IGF-1 Signaling and Aging’’).
Animals
The Igf1r
+/2 mice were kindly provided by Dr. Argiris Ef-
stradiatis (Columbia University College of Physicians and Sur-
geons, New York) who derived them in a 129Sv background by
homologous recombination, which ablated the third exon of the
Igf1r gene [14]. The mice were backcrossed into the C57Bl/6
background for at least 10 generations. To establish the colony of
mice used in this study, Igf1r
+/2 males were bred to C57BL/6 WT
(i.e., Igf1r
+/+) females purchased from the Jackson Laboratory (Bar
Harbor, ME), producing offspring of which half were Igf1r
+/2 and
half, WT. Mice were weaned into their final cages, genotyped, and
randomly assigned to the experiments. In all studies described
below, age-matched littermates were used as controls. The
genotypes of the mice were determined as described by Liu
et al. [14]. In the lifespan study, mice were maintained under
pathogen-free barrier conditions and permitted to die of natural
causes, i.e., there was no censoring of the animals. Cages assigned
to longevity experiments were checked twice daily for dead
animals but otherwise undisturbed. Upon death, the mice were
necropsied for gross pathological lesions as previously described
[19]. For each mouse, a list of pathological lesions was constructed
and graded as previously described [19–22]. All mice were fed a
standard NIH-31 chow ad libitum and maintained in micro-isolator
cages, 4 to a cage, on a 12-hour dark/light cycle. C57Bl/6 mice
are mature both sexually and with respect to body size at 6 months
of age. At 25 months of age, typically fewer than 15% of the mice
have died and pathology is minimum, so measurements are not
confounded by disease/pathology. Therefore these were the two
ages used in all the experiments presented here unless otherwise
indicated.
Paraquat and diquat
Paraquat was injected interperitoneally at dose of 50 mg/kg of
animal body weight. Diquat was injected interperitoneally at a
dose of 100 mg/kg for survival studies and 50 mg/kg for
hepatotoxicity studies. A Hamilton syringe demarcated in 2.5 ml
increments was used for the injection, making it possible to adjust
dosage for body weight differences as small as 0.6 g. To track the
survival of mice after paraquat or diquat treatment, the cages
containing the treated mice were placed under an array of digital
surveillance cameras (Strategic Vista, Ontario, Canada). These
cameras monitored the animals continuously, and the footage was
used to determine the time of death with a precision of 1 min. The
time of injection was subtracted from the recorded time of death to
obtain the survival time for each animal. For studies of diquat-
induced hepatotoxicity, mice were anaesthetized with a standard
ketamine/acepromazine/xylazine cocktail (0.02 cc/25 g body
weight) 6 hr after diquat administration (50 mg/kg) and 200–
400 ml of blood were collected by cardiac puncture then trans-
ferred to heparinized storage tubes. The animals were euthanized
by cervical dislocation, and livers were removed and preserved in
10% neutral buffered formalin. Blood collected from diquat-
treated mice was stored on ice in lithium heparin tubes, and as
soon as possible after collection, plasma was separated by cen-
trifugation for 10 min at 1.5 kG and 4uC. ALT activity in the
plasma was measured as per manufacturer’s instructions using the
ALT Colorimetric Kit from Teco Diagnostics (Anaheim, CA).
Liver samples in 10% neutral buffered formalin were paraffin
embedded, sectioned, and fixed on slides. Apoptotic cells in these
sections were identified on the basis of double strand DNA breaks
using the ApopTag Kit from Chemicon (Temecula, CA, USA).
Cell nuclei that were both dark and compacted were identified
under a light microscope and scored as apoptotic. The number of
apoptotic nuclei in the entire cross section was divided by cross
sectional area (arbitrary grid units) to give number of apoptotic
cells per cross sectional area of liver.
Real-time PCR
Mice were fasted overnight and tissues were removed and frozen
in liquid nitrogen. Total RNA was isolated using RNA STAT-60
(Tel-test, Friendswood, TX, USA). Single stranded cDNA was
synthesized from 3.0 mg of RNA using the High-capacity cDNA
Archive Kit (P/N 4322171; ABI, Foster City, CA, USA). Real-time
PCR reaction was performed using TaqMan Universal PCR
Master Mix (P/N 4324018) and TaqMan-MGB probes for IGF
-1 (Mm00439561_m1), IGF-1R (Mm00802831_m1) and B2M
(Mm00437762_m1) all of which were purchased from ABI. All
samples were run in duplicate and quantitated in an ABI 7500
thermal cycler.
In vivo IGF-1R signaling
After an overnight fast, mice were given an i.p. injection of
1 mg/kg body weight of rhIGF-1 (Austral Biologicals, San
Ramon, CA, USA) or an equivalent volume of sterile saline.
Ten min post injection, quadriceps muscle was collected and
frozen in liquid nitrogen. Whole tissue homogenates were
prepared and protein concentration was determined by Bradford
assay [23]. For immunoblotting, primary antibody directed against
Reduced IGF-1R Signaling in Igf1r
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purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA) and primary antibody directed against phospho-Akt (anti-
pAkt Ser473) and total Akt (anti-Akt) were purchased from Cell
Signaling Technologies (Danvers, MA, USA). For the glucose
tolerance assay, mice were fasted overnight. Blood glucose was
measured using an Accucheck glucometer (Roche Diagnostics,
Indianapolis, IN, USA) at 0, 30, 60 and 120 min after i.p. injection
of 2 g/kg body weight of dextrose. Insulin tolerance tests were
performed by fasting the mice for 4 hr followed by i.p. injection
of 0.5 U/kg body weight of insulin (Novolin, Novo Nordisk,
Princeton, NJ, USA). Blood glucose was measured at 0, 30, 60 and
90 min. Serum IGF-1 assays of unstimulated WT and Igf1r
+/2
animals were performed using kits from ALPCO (Windham, NH,
USA) as described by Delahunty et al. [24] to determine baseline
circulating IGF-1 levelsanimals to determine circulating IGF-1
levels were performed using kits from ALPCO (Windham, NH,
USA) as described by Delahunty et al. [24].
Euglycemic hyperinsulinemic clamps
Insulin clamps were done as described by Wang et al. [25]. Five
days prior to insulin clamp, mice were anesthetized using 150 mg
ketamine, 30 mg xylazine and 5 mg acepromazine sc, and a
catheter was inserted into the right jugular vein. Clamps were
performed on awake, unrestrained mice. At the start of the experi-
ment, a primed (5.3 ml/h61 min) continuous (0.3 ml/h) infusion
of human insulin (3.6 mU/min/kg) was started simultaneously
with a variable infusion of 10% dextrose in order to maintain
euglycemic conditions. Blood glucose levels were monitored by tail
vein sampling. At the end of the clamp, animals are anesthetized
with ketamine, and tissues were collected.
Statistics
The Cox-Mantel Log rank test was used to evaluate all survival
curves. Quantile regression as described by Koenker [26] was used
to compare means and medians. The Student’s t-test was used for
all two-sample comparisons reported other than survival data. For
all statistical tests returning significant p-values, these p-values are
reported to the first significant digit. Pathological lesions in post-
mortem samples collected from mice in the longevity study were
graded for severity on a scale of 1–4. For each lesion in each
organ, both severity and incidence were analyzed using the
following formula:
X ~ genotype z age z genotype:age
where X is incidence, severity, or burden ðÞ
For incidence (presence or absence of a lesion) the above formula
was used in a general linear model with a binomial error
distribution. For severity, the above formula was used in a
proportional-odds logistic regression model. For each organ,
neoplastic, non-neoplastic, and overall disease burdens (i.e., the
number of distinct lesions observed in that organ) were also
compared as was the aggregate severity of each type of lesion (i.e.,
the number of different organs in which that lesion was observed).
Finally, the animal-level disease burden (number of distinct lesions
per animal) was compared for neoplastic, non-neoplastic, and
overall lesions. For the three animal-level comparisons, the
following lesions were only counted once per animal even if they
were detected in more than one tissue: lymphacytic infiltration,
lymphoma, suppurative inflammation, carcinoma, metastatic
carcinoma, adenobranchiolar carcinoma, pheochromocytoma,
and lymphoid hyperplasia. These tests were done for any lesion
or grouping of lesions that occurred in more than five animals
of the same genotype. Male and female data were analyzed
separately. Altogether, 50 distinct lesions or groups of lesions were
analyzed in males and 53 in females and the Holm [27] method
was used to correct for multiple comparisons. The R statistical
language [28] with the binom [29] and car [30] packages was used
for the pathology analysis. In addition, the quantreg [26],
surv2sample [31], and eha [32] packages were used for survival
analysis.
Results
Characterization of Igf1r
+/2 Mice
The body weights of male and female Igf1r
+/2 mice were 9%
(20.8 vs. 22.8, p,0.001) and 12% (16.2 vs. 18.2, p,0.001) lower
than those of their WT littermates, respectively. The expression of
IGF-1R was measured in young (6 months) and old (25 months)
WT and Igf1r
+/2 mice. The levels of Igf1r mRNA were
significantly reduced (,50%) in all tissues studied from young
(Figures 1a and 1c) and old (Figures 1b and 1d) Igf1r
+/2 mice of
both sexes and paralleled by a decrease in Igf1r protein levels as
shown in Figures 1e and 1g which is similar to that reported for
young mice by Holzenberger et al. [15]. However, we also show in
Figures 1f and 1h that the expression of IGF-1R is reduced in old
mice. The reduced expression of Igf1r had no effect on serum
IGF-1 levels (Table S1) or tissue expression (mRNA levels) of IGF-
1 in various tissues, with the exception of kidneys in young males
(Table S2).
Previously, Holzenberger et al. [15] showed that the IGF-1
signal as measured by IGF-1-induced phosphorylation of IGF-1R,
Figure 1. Igf1rb expression. The mRNA and protein levels of the b
subunit of Igf1r were measured in the kidney, lung, and muscle
(quadriceps) from male and female mice that were 6 (Graphs A, E, C,
and G) and 25 (Graphs B, F, D, and H) months old. The graphs on the left
represent data from qRT-PCR and those on the right represent data
from Western blots. Three to 6 animals were used per group. Black bars
represent WT mice and red bars represent Igf1r
+/2 mice; the mean and
SEM are shown, and asterisks indicate tissues showing a difference
between WT and Igf1r
+/2 where p,0.05. The Student’s t-test was used
for the comparisons.
doi:10.1371/journal.pone.0026891.g001
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from Igf1r
+/2 mice. To determine whether reduced IGF-1R levels
compromise signaling in whole animals, we compared the ability
of Igf1r
+/2 and WT mice to respond to a bolus of IGF-1 in vivo by
measuring the phosphorylation of Akt in muscle. Akt phosphor-
ylation in muscle was induced by IGF-1 in all mice: young
(Figures 2a and 2c) and old (Figures 2b and 2d), WT and Igf1r
+/2.
However, induction of Akt in both male and female Igf1r
+/2 mice
was approximately half that observed in the WT mice. Akt inhibits
GSK3b by phosphorylating it, and IGF-1 signaling induces Igfbp5
expression [33,34] therefore we also measured the phosphoryla-
tion of GSK3b and mRNA transcript levels of Igfbp5 in the
quadriceps of WT and Igf1r
+/2 mice. We observed a decrease
both in IGF-1 stimulated phosphorylation of GSK3bb (Figures 3a
and 3b) and in Igfbp5 transcript levels (Figures 3c and 3d),
confirming a reduction of IGF-1 dependent signaling in Igf1r
+/2
mice as would be predicted for a biologically significant
impairment of IGF-1R function.
Glucose and Insulin Tolerance Tests
Holtzenberger et al. [15] reported that adult male Igf1r
+/2 mice,
but not female Igf1r
+/2 mice, were less glucose tolerant than WT
mice when given a bolus of glucose. In our study, we measured both
glucose and insulin tolerance in young (5 months) and old (25
months) male and female Igf1r
+/2 and WT mice. We found that
young male and female Igf1r
+/2 mice showed the same glucose
tolerance as age-matched WT mice (Figures 4a and 4b). In contrast,
old male Igf1r
+/2 mice were significantly less glucose tolerant
compared to old male WT mice whether assessed by comparison of
blood glucose levels at each time point post-glucose injection or as
AUC (Figure 4c) while old female Igf1r
+/2and WT mice showed no
difference in glucose tolerance (Figure 4d). Of interest, when
comparing young and old wt mice, old mice were more glucose
tolerant than young mice and also had lower fed levels of serum
glucose. Our observation of paradoxical age-related enhancement
of glucose tolerance is exactly as has been reported previously in
wild type C57BL/6J mice by Leiter’s lab [35]. Young male and
female Igf1r
+/2 and WT mice experienced similar declines in blood
glucose after insulin injection (Figures 4e and 4f). )ld Igf1r
+/2 males
showed a significantly attenuated response to an insulin challenge as
compared to WT mice (Figure 4g). The old Igf1r
+/2 female mice,
though glucose tolerant, displayed an overall trend toward insulin
resistance compared to WT mice (Figure 4h). Therefore, we
measured insulin sensitivity in the old female Igf1r
+/2 and WT mice
using the hyperinslinemic-euglycemic clamp. As shown in Figure 5,
the glucose infusion rate required to maintain euglycemia was
significantly lower in the aged Igf1r
+/2 females as compared to the
WT, indicating that female Igf1r
+/2 mice were less sensitive to the
glucose lowering effect of insulin.
Sensitivity of Igf1r
+/2 Mice to Oxidative Stress
Paraquat is a superoxide-anion generator that is commonly used
to induce oxidative stress in cells and whole animals and was used
Figure 2. Induction of AKT phosphorylation by IGF-1 in WT and
Igf-1r
+/2 mice. Levels of phosphorylated AKT were measured in the
muscle (quadriceps) of 6- (graphs A and C) and 25- (graphs B and D)
month-old male and female mice following injection of saline or rhIGF-1
(1 mg/kg body wt.) using Western blots as described in Materials and
Methods. Three to 4 animals were used per group.
doi:10.1371/journal.pone.0026891.g002
Figure 3. Induction of GSK3b phosphorylation and levels of Igfbp5 mRNA transcript in WT and Igf1r
+/2 mice. Levels of phosphorylated
GSK3b were measured in the muscle (quadriceps) of 25-month-old male (graph A) and female (graph B) mice following injection of saline or rhIGF-1
(1 mg/kg body wt.) using Western blots as described in Materials and Methods. Three animals were used per group. The expression of Igfbp5 was
measured in the same samples using qRT-PCR (graphs C and D). The vertical axis represents expression levels relative to B2M and the error bars
represent SEM. P-values of 0.01 and 0.005 are represented by * and **, respectively.
doi:10.1371/journal.pone.0026891.g003
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Igf1r
+/2 mice were more resistant to oxidative stress than WT
mice. Male Igf1r
+/2 and WT mice show no statistically significant
difference in survival when given a lethal dose of paraquat; 89% of
the WT mice and 92% of the Igf1r
+/2 mice died within eight days
(Figure 6a). However, female Igf1r
+/2 mice were more resistant to
paraquat toxicity; 82% of the WT female mice died during the 8-
day observation period compared to 37% of the Igf1r
+/2 mice
(Figure 6b).
Because the effect of paraquat is concentrated mainly in the
lung, we also compared the sensitivity of Igf1r
+/2 and WT mice to
diquat, another superoxide anion generator that affects a variety of
tissues to assess the generality of the increased resistance of the
female Igf1r
+/2 mice to oxidative stress. Again, there was no
significant difference between WT and Igf1r
+/2 male mice; all
mice died within 31 hours of diquat administration (Figure 6c).
However, the female Igf1r
+/2 mice showed a significantly
increased resistance to diquat toxicity; all WT females died within
36 hours of treatment but only 60% of the Igf1r
+/2 females did so
(Figure 6d). We also determined the sensitivity of the liver of
female WT and Igf1r
+/2 mice to oxidative stress by measuring the
activity of alanine-leucine transaminase (ALT) in the plasma six
hours after treatment with a sub-lethal dose of diquat. ALT
activity of Igf1r
+/2 mice was significantly (42%) lower compared
to WT mice (Figure 6e) indicating reduced liver damage in the
Igf1r
+/2 mice. In the same mice, we measured the induction of
apoptosis in liver and found a significant reduction (64%) of
apoptotic cells in Igf1r
+/2 mice compared to WT mice (Figure 6f).
Thus, female Igf1r
+/2 mice show increased resistance to diquat-
induced toxicity both in the liver and at the whole animal level.
Longevity and End-of-Life Pathology of Igf1r
+/2 Mice
The survival curves for male and female Igf1r
+/2 and WT mice
are shown in Figures 7a and 7b, respectively, and the detailed
statistical analysis of the survival data are given in the Table 1. The
mean survival of the WT male and female mice was 32.8 and 30.8
months, respectively, and fewer than 7% of the mice of either sex
or genotype died before 20 months of age. Thus, the baseline
lifespans in our aging colony are optimal, clearly not limited by
disease or environmental stress and are representative of age-
related processes independent of preventable extrinsic causes. The
mean and median survival of the male Igf1r
+/2 mice were slightly
(4 to 8%) shorter than the male WT mice; however, these
differences were not statistically significant, nor were the overall
distributions of survival times according the log-rank test. The
female Igf1r
+/2 mice showed a 5 to 7% increase in mean, median,
and 90
th percentile survival compared to female WT mice; and,
these differences also were not significant; however, the overall
distributions of survival times were significantly different at the
P = 0.02 level according to the log-rank test.
We also conducted a comprehensive analysis of end-of-life
pathology in the 222 mice used in the lifespan study. As expected
for mice in the C57BL/6 background at the end of life [36,37], the
most common neoplastic lesion in both sexes and genotypes was
lymphoma, which affected 75 to 89 percent of the mice. In male
mice, the only lesions showing any evidence of a difference in
incidence were the 36% decrease in all fatal tumors and the 47%
decrease in fatal lymphoma in Igf1r
+/2 mice compared to WT
mice (Table S3); however, these differences do not attain
significance when corrected for multiple comparisons. In female
mice, only the incidence of lymphocytic infiltrates, which is one
measure of chronic inflammation, showed any evidence for a
difference between Igf1r
+/2 and WT mice (a 30% decrease in
Igf1r
+/2 mice) (Table S4); however, these differences also do not
attain significance when corrected for multiple comparisons. We
also measured the severity of the major pathological lesions in
Igf1r
+/2 and WT mice (Table S5). The only lesions that showed
any evidence for a difference in severity were all fatal tumors in
Figure 4. Glucose and Insulin Tolerance Tests. GTTs (2 g/kg, i.p.)
were performed in 6-month-old male (A) and female (B) as well as 25-
month-old male (C) and female (D) mice after a 12 hr fast, and blood
glucose was recorded at times indicated. ITTs (0.5 U/kg, i.p.) were
performed in 6-month-old male (E) and female (F) as well as 25-month-
old male (G) and female (H) mice after a 5 hr fast. The data were
obtained from 6 to 8 animals per group and the SEM is shown. Black
lines show the blood glucose levels of WT (black lines) and Igf1r
+/2 mice
(red lines). The Student’s t-test was used for the comparisons of the
areas under the curve (AUC) and the p-values are shown on each graph.
Individual points were also compared in the same manner and
corrected for multiple comparisons, and corrected p-values less than
0.05 are denoted by asterisks.
doi:10.1371/journal.pone.0026891.g004
Figure 5. Peripheral Insulin Sensitivity. Peripheral (muscle) insulin
sensitivity was measured with a 90 min hyperinsulinemic euglycemic
clamp performed in 4 WT and 5 Igf1r
+/2 females, all 25 months old. Bars
represent the average 6 SE glucose infusion rate during the last 20 min
of the clamp. A student’s t-test was used to compare the infusion rates
between the two groups, averaged over the 20 min period for each
animal.
doi:10.1371/journal.pone.0026891.g005
Reduced IGF-1R Signaling in Igf1r
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+/2 mice) and lymphocytic infiltrates
in females (a 52% decrease in Igf1r
+/2 mice). However again, these
differences do not attain significance when corrected for multiple
comparisons. The total disease burden and tumor burden of the
Igf1r
+/2 and WT mice were also measured because previous
studies show that disease burden is significantly reduced in
established mouse models of longevity, e.g., dietary restriction
[21], Ames Dwarf mice [20], and growth hormone receptor
knockout mice [22]. No significant differences were observed in
either disease or tumor burden between Igf1r
+/2 and WT mice for
either males or females (Table S6). Thus, our detailed pathological
analyses of Igf1r
+/2 mice show that reduced IGF-1 signaling had
no major effect on end-of-life pathology in either male or female
mice as would be predicted if reduced IGF-1 signaling delayed
aging.
Discussion
The major observation of our study is that reduced IGF-1
signaling had no significant effect on the mean, median, or 90%
survival of either male or female Igf1r
+/2 mice compared to WT
mice. Only when the overall distributions of survival times were
analyzed by the log-rank test was a significant difference observed
between WT and female Igf1r
+/2 mice (mean survival was
increased less than 5%, p=0.02). This finding is in sharp contrast
to the previous study by Holzenberger et al. [15], which reported
that the mean lifespan of female Igf1r
+/2 mice was increased 33%
compared to WT mice (756646 vs. 568649 compared to the
967629 vs. 923621 from our study shown in Table 1). It should
be noted that we studied larger cohorts of 47 to 68 animals, which
allowed us to detect a 10% change in mean survival with a power
of 0.8 [16].
We identified three likely explanations for the disparity between
our observations on lifespan and those by Holzenberger et. al [15].
First, is the possibility that the mutations in the two Igf1r
+/2 mouse
models are not equivalent because they were produced indepen-
dently by two laboratories using different methods for generating
knockout mice. The Holzenberger Igf1r
+/2 mice were produced
by replacing exon 3 of Igf1r (which encodes most of the ligand
binding domain on the a subunit of the receptor), with a loxP
flanked exon 3 that had an adjacent neomycin resistance cassette.
The entire segment was then deleted by crossing into Cre
expressing mice. In contrast, the Efstratiadis group [14] performed
Figure 7. Longevity of WT and Igf1r
+/2 mice. The survival curves of 55 WT and 52 Igf1r
+/2 male mice (A) and 68 WT and 47 Igf1r
+/2 female (B)
mice are shown in black for WT mice and red for Igf1r
+/2mice. The survival curves were compared using the log-rank test, and the p-values are shown.
doi:10.1371/journal.pone.0026891.g007
Figure 6. Sensitivity of WT and Igf1r
+/2 mice to oxidative stress. Paraquat (50 mg/kg) was administered to 37 male WT mice and 26 male
Igf1r
+/2 mice (graph A) as well as to 39 female WT mice and 24 female Igf1r
+/2mice (graph B). Diquat (50 mg/kg) was administered to 21 WT and 26
Igf1r
+/2 male mice (graph C) as well as to 22 WT and 17 Igf1r
+/2 female mice (graph D). The mice in graphs A–D were 5 to 9.5 months of age.
Censored data points (due to uncertainty about the exact minute of an animal’s death) are indicated by vertical tick-marks. Graphs E and F: Female
WT and Igf1r
+/2 mice (10 to 11 months of age) were treated with diquat (50 mg/kg). Six hours after treatment the mice were killed and the ALT
activities in the plasma (graph E) and number of apoptotic cells per unit area in a liver cross section (graph F) of 7 WT and 8 Igf1r
+/2mice were
determined. The mean and SEM are shown in the bar graphs. Black represents WT data and red represents Igf1r
+/2data. Survival data were analyzed
using the log-rank test while the ALT and apoptosis data were analyzed using Student’s t-test and the p-values are shown.
doi:10.1371/journal.pone.0026891.g006
Reduced IGF-1R Signaling in Igf1r
+/2 in Mice
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e26891a traditional knockout of the same exon, directly replacing it by
homologous recombination. However, in both cases, virtually the
same region was removed. Furthermore, both the Holzenberger
laboratory [15], the Efstratiadis laboratory [14], and our
laboratory observed ,50% decrease in IGF1r expression in
tissues of the Igf1r
+/2 mice using quantitative RT-PCR and
Western blots. Therefore, we do not believe that the differences in
how the respective knockout mice were generated have any effect
of IGF-1R expression and are responsible for the contradictory
lifespan data.
The second possibility is that the difference in lifespan is due to
the genetic background of the Igf1r
+/2 mice because the mice used
by Holzenberger et al. [15] were on the 129/J background, and
the mice used in our study were on the C57Bl/6 background. We
believe that it is unlikely that this is the reason for the
contradictory lifespan data because all the other major phenotypes
reported for the Igf1r
+/2 mice by Holzenberger et al. [15] are
similar to what we observed. For example, both studies show the
Igf1r
+/2 mice have slightly smaller body weights (,10%) than WT
mice, Igf1r
+/2 mice show ,50% decrease in IGF-1R expression
and reduced IGF-1 signaling, and male Igf1r
+/2 mice show
impaired glucose tolerance on the glucose tolerance test. In
addition, our data on the sensitivity of the mice to paraquat were
virtually identical to that reported by Holzenberger et al. [15];
male Igf1r
+/2 and WT mice had a similar paraquat sensitivity
while female Igf1r
+/2 mice showed significant resistance to
paraquat compared to female WT mice. In an ongoing study,
we are measuring the lifespan of female Igf1r
+/2 mice on a
C57BL/66 129Sv F1 background. As shown in Figure S1, with
the majority of animals in both groups dead, we observe no
statistically significant difference between the censored survival
curves of WT and Igf1r
+/2 mice nor between median survival
times. Thus, these preliminary data argue against strain back-
ground accounting for the observed results.
The final possibility, which we consider the most likely
explanation for the differences between our lifespan data and
those reported by Holzenberger et al. [15] is the number of
animals used in the lifespan studies and the housing conditions.
Holzenberger et al. [15] used a relatively small number of mice in
their lifespan study (12 to 20 mice per group). In our study, 47 to
68 mice per group were used. Using larger sample sizes reduces
the effects of uncontrolled variables, such as maternal- or paternal-
specific effects on lifespan [38]. In other words, a larger sample
size reduces the influence that each animal has on group
summaries of survival. Therefore, the lifespan data are less likely
to be distorted by any outlying observations and are more
reproducible. However, we believe that differences in housing
conditions, as evidenced by the length of the lifespans of the mice
in the two studies, is also a major factor in the contradictory
lifespan data. The mean lifespans of the WT and Igf1r
+/2 female
mice reported by Holzenberger et al. [15] were 568 and 756 days,
respectively, while the WT and Igf1r
+/2 male mice lived an
average of 585 and 679 days, respectively. In fact, 40% of the
female WT mice died by 12 months of age. In contrast, the mean
lifespans of 129/J mice maintained at The Jackson Laboratory are
reported to be 776 days and 855 days for female and male mice,
respectively [39]. In other words, the lifespan of the WT 129/J
female mice in the study by Holzenberger et al. [15] are 37%
shorter than the lifespan reported at The Jackson Laboratory, and
the Igf1r
+/2 female mice merely attain a normal mean lifespan for
this strain of mice. The lifespan parameters of the C57BL/6 mice
in our study are in line with or greater than that reported by other
groups, e.g., National Institute on Aging [40] or The Jackson
Laboratory [39], for C57Bl/6 mice maintained under contempo-
rary pathogen-free, barrier conditions. For example, the mean
lifespan of the male and female WT mice were 983 and 923 days,
respectively, and fewer than 7% of the mice of either sex or
genotype died before 20 months of age. By maximizing the
lifespan of the mice, we have minimized the effect of genotype/
environment interactions on lifespan, i.e., one has a more accurate
measure of the effect of the genetic manipulation on aging. We
propose that that the increase in the lifespan of the female and not
male Igf1r
+/2 mice observed by Holzenberger et al. [15] was due
largely to the increased resistance of the female Igf1r
+/2 mice to
stress. Therefore, when the female mice are maintained in a more
optimal and less stressful environment where they are able to live
out their lifespan, such as in our study, no major difference in the
lifespan of female Igf1r
+/2 and WT mice is observed. A similar
observation was made for mice lacking methionine sulfoxide
reductase-A (MsrA). Moskovitz et al. [41] reported that the MsrA
knockout mice, which are sensitive to oxidative stress, had a
shorter lifespan than WT mice when maintained in a colony with
a relatively short lifespan (e.g., the mean lifespan of WT mice was
680 days). However, when the MsrA knockout mice were
maintained under husbandry conditions that give optimal lifespan
(e.g., the mean lifespan of the WT mice was 925 days), Salmon
et al. [42] showed that the lifespan of the MsrA knockout and WT
mice were identical.
Although lifespan data are critical in determining whether a
manipulation retards aging, pathological data are also necessary
because a pathological assessment gives one the likely cause of
death and how the progression of pathological lesions are affected
Table 1. A summary of lifespan data for WT and Igf1r
+/2 mice.
Male Female
WT Igf1r
+/2 % Change P WT Igf1r
+/2 % Change P
N 5 55 2 6 84 7
Mean
SE M
983
21
939
24
24.5 0.16 923
21
967
29
4.7 0.22
Median
(±95% CI)
1004
(937, 1048)
920
(873, 1013)
28.4 0.53 948
(896,1001)
1013
(924,1062)
6.9 0.64
90
th Percentile
(±95% CI)
1139
(1128, 1240)
1160
(1138, 1205)
1.8 0.82 1110
(1091, 1127)
1184
(1143,1290)
6.7 0.26
In addition to the log-rank test, the means from the survival data shown in Figure 6A were compared using a bootstrap t-test and the medians and 90
th percentiles were
compared using quantile regression as described in Materials and Methods.
doi:10.1371/journal.pone.0026891.t001
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manipulation affects age-related diseases [43]. For example, a wide
variety of age-related pathological lesions are significantly delayed
and/or reduced in three mouse models that show delayed aging,
e.g., dietary restriction [21,44], Ames Dwarf mice [20], and
growth hormone receptor knockout mice [22]. In addition, these
manipulations reduce the severity of many of the major
pathological lesions and reduce the disease burden. The extensive
pathological data we have obtained on the Igf1r
+/2 mice show no
significant decrease in either the incidence or severity of any
pathological lesion and no difference in disease burden compared
to WT mice. Thus, the absence of an effect of IGF-1 signaling on
end-of-life pathology is quite different than that observed with
other manipulations that have been well documented to enhance
longevity and retard aging in mice.
In summary, our lifespan and pathology data show that the
Igf1r
+/2 mouse is not a model of delayed aging. These data have
important consequences for the field of aging because it is well
established that loss-of-function mutations in the insulin/IGF-1
signaling pathway lead to increased lifespan and an anti-aging
phenotype in invertebrates [45]. Especially relevant to this study are
the mutations in the daf-2 gene in C. elegans and the InR gene in
Drosophila that effect the function of the insulin/IGF-1 receptor. C.
elegans and Drosophila have only one receptor for insulin and IGF-1,
while mammals, such as mice and humans, have two different
receptors, one for insulin and one IGF-1, each coded by a separate
gene. Our data demonstrate quite clearly that reducing IGF-1
signaling approximately 50% in Igf1r
+/2 mice has very little effect
on lifespan and end-of-life pathology, i.e., there is no evidence that
these animals exhibit an anti-aging phenotype as has been observed
in invertebrates when a loss of function occurs in the insulin/IGF-1
receptor. In addition, it has been argued that the decrease in
circulating IGF-1 levels in dietary restricted mice [46], Ames and
Snell dwarf mice [47,48], and growth receptor knockout mice [49]
plays an important role in the extended lifespan of these models
through reduced IGF-1 signaling [45]. The Igf1r
+/2 mouse model
has allowed us to study the effect of just reduced IGF-1 signaling on
lifespan/aging from the many other pathways that are affected by
dietary restriction and dwarfism. Our data demonstrate clearly that
neither male nor female Igf1r
+/2 mice show the increase in lifespan
or reduced/delayed pathology that is observed in male and female
mice that are dietary restricted or have mutations resulting in the
dwarf phenotype. Based on these data, we conclude that the
reduced circulatingIGF-1levelsindietaryrestrictedand dwarfmice
play little if any role the anti-aging phenotype observed in these
mice. In the case of dwarfs, it seems reasonable to conclude that
reduced GH signaling per se is far more important than reduced
IGF-1 in lifespan extension. Moreover, one common characteristic
of dwarf mice and CR rodents is increased insulin sensitivity
[50,51]; in contrast, Igf1r
+/2 mice do not have increased insulin
sensitivity, and in fact become insulin resistant as they age. In
addition, old male Igf1r
+/2 mice develop glucose intolerance (with
females exhibiting a tendency to glucose intolerance). Of interest
with respect to gluco-regulation in mice, our old wt mice were more
glucose tolerant than young wild type mice. This paradoxical
enhancement of glucose tolerance in old C57Bl/6J mice has been
previously reported by Leiter and colleagues [35], and has been
attributed to increased beta cell insulin secretory capacity in old
C57Bbl/6J wild type mice. This in turn suggests that the relative
glucose-intolerance in old male Igf1r
+/2 mice is due to insulin
resistance and a relative failure of the glucose sensing capacity in
their beta cells thereby impairing glucose simulated insulin
secretion. A direction for future research would be to test this
hypothesis via islet morphometry and glucose-stimulated insulin
release studies. Our present results suggest that haploinsufficiency of
IGF-1R increases the probability for developing type 2 diabetes by
diminishing peripheral insulin action and by preventing glucose
stimulated compensatory increase in insulin secretion.
Our experiments follow the generally accepted reductionist
paradigm in that optimal conditions (e.g., nutrition, temperature,
humidity) and essentially a pathogen-free environment are used to
isolate the underlying process of organismal aging from prevent-
able pathologies as much as possible. In light of these results it
appears that Holzenberger’s group has demonstrated that female
Igf1r
+/2 are rescued from some as-yet unidentified environmental
stressor, and we have demonstrated that the intrinsic aging process
is not affected by this mutation. However, as with any other
animal experiment conducted under carefully controlled condi-
tions, caution is advised in drawing inferences about other species,
particularly humans. Even with access to state of the art health
care, humans clearly do not live under optimal conditions. The
stressor against which female Igf1r
+/2 mice are protected may well
be clinically relevant and identifying this stressor would be an
important avenue for future research. Such a search would
nevertheless need as its starting point an environment where
nothing interferes with an animal living to its naturally attainable
lifespan except a candidate stressor against which the Igf1r
+/2
genotype is believed to be protective.
Supporting Information
Figure S1 Lifespan of Female WT and Igf1r
+/2 Mice on
a C57BL/6X129Sv F1 Background. Male C57Bl/6 Igf1r
+/2
mice were crossed to female 129 mice to generate female WT and
Igf1r
+/2 mice on a C57BL/6x129Sv F1 background. Of the 66
WT mice, 47 mice died from natural causes, 5 mice were
censored, and 14 mice were alive at the time of data analysis. Of
24 Igf1r
+/2 mice, 16 mice died of natural causes and 8 mice were
alive at the time of data analysis. Lifespans of female C57BL/66
129Sv F1 hybrids were analyzed using the log-rank test an no
significant difference was found (P=0.48). The median survivals
were 1009 days (95% confidence interval 963–1079 days) for the
WT mice and 1016 days (95% confidence interval 956–1170) for
the Igf1r
+/2 mice.
(PDF)
Table S1 Circulating Levels of IGF-1. Serum from three
mice from each group was assayed for IGF-1 as described in
Materials and Methods, and the IGF-1 levels (expressed in ng/ml)
are shown.
(PDF)
Table S2 Igf1r Expression. The mRNA levels of Igf1r were
measured in the indicated tissues from male and female mice at 6
and 25 months of age. The mean and SEM columns are for
DDCT values of Igf1r mRNA normalized to the median
expression level of the male WT group in each respective tissue.
The Student’s t-test was used for the comparisons. The p-values
are shown with the tissue having a p,0.05, highlighted.
(PDF)
Table S3 Incidence of Lesions in Males. The presence or
absence of each lesion or category of lesions shown was coded as 0
or 1, respectively, for each animal. Where a lesion was judged to
have caused the death of an animal, the total incidence and the
incidence of just the fatal instance of that lesion are shown on
separate lines indented below the name of the lesion. Where data
were obtained for both a category of lesion and organ-specific
lesions within that category, the latter are shown indented below
the name of the category. Otherwise the lesions are listed from
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could not be analyzed due to autolysis. Lesions that had an
incidence of 9 or more in the WT and/or Igf1r+/2 mice were
selected for statistical analysis. For each such lesion, a logistic
regression model was fitted with incidence as the response variable
and genotype, age, and the age-genotype as the covariates. The
p-values from the genotype and age:genotype effects were adjusted
for multiple comparisons using the Holm method [27]. The raw
and adjusted p-values for the genotype effect are shown. None of
the age:genotype p-values approached significance. The highlight-
ed rows indicate lesions where the uncorrected p-values are less
than 0.05. Given that none of these values were significant after
adjustment, the highlighted values should be interpreted as a
possibly meaningful trend rather than a significant difference.
(PDF)
Table S4 Incidence of Lesions in Females. See legend for
table S3.
(PDF)
Table S5 Males and Females, Severity. Organ-specific
lesions (glomerulonephritis, gonadal degeneration, nephrocalcino-
sis, pituitary adenoma, and subscapular hyperplasia) were assigned
a severity grade as described in Methods by Ikeno et. al. [20–22].
For lymphoma and lymphocytic infiltration, the number of organs
where those lesions were observed was used as a measure of whole-
organism severity. A logistic regression model was fitted to the
organ-specific data and a linear model was fitted to the lymphoma
and lymphocytic infiltrate data. In all cases, severity was the
response variable and genotype, age and the age-genotype
interaction were the covariates. The p-values for the genotype
and age-genotype effects were adjusted for multiple comparisons
using the Holm method [27]. The raw and adjusted p-values for
the genotype effect are shown. None of the age-genotype p-values
approached significance. The highlighted rows indicate lesions
where the uncorrected p-values are less than 0.05. Given that none
of these values were significant after adjustment for multiple
comparisons, the highlighted values should be interpreted as a
possibly meaningful trend rather than a strongly significant
difference.
(PDF)
Table S6 Males and Females, Disease Burden. Disease
burden is defined as the number of distinct lesions observed in an
animal (either total lesions or only neoplastic ones) as described in
Materials and Methods. In calculating neoplastic burden, lesions
were counted separately for each organ in which they were
observed with the exception of lymphoma, which was counted
only once regardless of how many organs it was found in. The p-
values from the genotype and genotype-age effects were adjusted
for multiple comparisons using the Holm method [27]. The raw
and adjusted p-values for the genotype effect are shown. None of
the genotype-age p-values approached significance.
(PDF)
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